Marco Bueter

TL;DR: The Swiss Multicenter Bypass or Sleeve Study (SM-BOSS), a 2-group randomized trial, was conducted from January 2007 until November 2011 (last follow-up in March 2017) as mentioned in this paper.

TL;DR: The progressive accumulation of exhausted, unconventionally activated CD8+PD1+ T cells in NASH-affected livers provides a rationale for stratification of patients with HCC according to underlying aetiology in studies of immunotherapy as a primary or adjuvant treatment.

TL;DR: Subsequent to Roux-en-Y gastric bypass, patients display markedly changed eating behaviour and meal patterns, which may lead to sustained weight loss.

TL;DR: The morbidity following closure of a temporary loop ileostomy in colorectal cancer patients is much higher in patients receiving adjuvant chemotherapy or radiochemotherapy, and the morbidity might possibly be lowered to the level of patients receiving no additional therapy if ilestomy closure is performed before the start of adjUvant therapy.

TL;DR: Nissen fundoplication appears to control reflux better than a partial Fundoplication, and overall outcome is good after 10 years.